Innovation
AACR 23 Posters
GTC presented abstracts at AACR 2023 GTC’s posters from 2023 Convention of American Association for Cancer Research are now available to be downloaded. Please reach
April 20, 2023 10:49 am
Read More »
Innovation
Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery and Development
Baltimore, MD and Irvine, CA, April 13, 2023, Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm, and Genomic Testing Cooperative
April 13, 2023 7:00 am
Press Releases
Genomic Testing Cooperative to Present at the AACR 2023 Meeting
Demonstrating Reliability of Targeted Transcriptomic Profiling in Predicting Levels of HER2, ER, PD-L1 and Other Immunohistochemistry-based Biomarkers when Combined with Artificial Intelligence Irvine, California– April
April 11, 2023 4:05 am
Innovation
In Move to Power Precision Oncology for Patients, COTA and Genomic Testing Cooperative Form New Data Partnership
Combining Longitudinal Real-World Data and Clinical Genomics Data Will Enable a More Precise Approach to Cancer Care and Research NEW YORK – COTA, Inc., an
March 8, 2023 5:05 am
Press Releases
Genomic Testing Cooperative to Present Data at the American Society of Hematology Meeting on New Applications of its Proprietary Tests that Combine Transcriptome Data Obtained from Tissue or Liquid biopsies with Machine Learning
Irvine, California– December 6, 2021 – Genomic Testing Cooperative, LCA (GTC) announced the presentation of four innovative studies at the annual American Society of Hematology
December 6, 2022 4:00 am
Publications
New paper in Journal of Medical Artificial Intelligence
GTC was recently published in the Journal of Medical Artificial Intelligence – Accuracy of predicting IgHV mutation status in chronic lymphocytic leukemia using RNA expression profiling and machine learning.
November 8, 2022 10:44 am
Innovation
Genomic Testing Cooperative Implementing AI, Molecular Profiling to Improve Cancer Diagnosis
CHICAGO – With the publication of a paper validating two artificial intelligence-based algorithms for assisting pathologists in molecular profiling of patients, the Genomic Testing Cooperative
November 3, 2022 9:02 am
Press Releases
Genomic Testing Cooperative and its Co-Op Members First to Use Artificial Intelligence to Distinguish Between 45 Hematologic and Solid Neoplasms Using Targeted Transcriptome
IRVINE, CA- Genomic Testing Cooperative, LCA (GTC) announced that its innovative artificial intelligence (AI) algorithms are now formally implemented in daily use to aid pathologists in the
October 13, 2022 4:00 am
Article
Case Study: VEXAS Syndrome
Background VEXAS syndrome is a disease with inflammatory and hematologic (blood) manifestations. The syndrome is caused by mutations in the UBA1 gene affecting the Met41 residue of
June 8, 2022 11:20 am